[06/26/24]
Posted on June 26, 2024 in Health Law News
Published by: Hall Render
Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework. Hall Render’s PE team of attorneys and advisors leverage... READ MORE
Tags: PRIVATE EQUITY, Private Equity Deal Spotlight
[06/21/24]
Posted on June 21, 2024 in Health Law News
Published by: Hall Render
In May 2024, the U.S. Food and Drug Administration (“FDA”) issued a Final Guidance titled “Remanufacturing of Medical Devices,” clarifying the definition of “remanufacturing” for reusable medical devices in need of maintenance or repair (“Final Guidance”). According to the FDA, the Final Guidance is designed to help medical device servicers understand when certain device... READ MORE
Tags: FDA, Medical Devices, Remanufacturing of Medical Devices, U.S. Food and Drug Administration
[06/21/24]
Posted on June 21, 2024 in Health Law News, HR Insights for Health Care
Published by: Hall Render
As previously discussed here, on April 23, 2024, the Federal Trade Commission (“FTC”) voted to adopt a final rule banning a majority of workers’ non-compete clauses (“Final Rule”). The Final Rule is set to go into effect on September 4, 2024. Nevertheless, pending litigation may delay the Final Rule or negate it entirely, and... READ MORE
Tags: Federal Trade Commission, FTC, Non-Compete Ban
[06/21/24]
Posted on June 21, 2024 in Health Law News, Health Provider News
Published by: Hall Render
NATIONAL 50% of U.S. military bases are in a health care desert, NPR probe finds AHA blog pushes back on report on nonprofit hospitals AMA adopts new prior authorization reform policies Change Healthcare cyberattack: CMS to end relief funding program CMS extends dispute process amid Change hack CMS closes headquarters after Legionella detected FDA... READ MORE
[06/20/24]
Posted on June 20, 2024 in Health Law News, Hospital Real Estate Briefing
Published by: Hall Render
Health systems are planning more construction projects focused on long-term growth and outpatient care, often renovating and repurposing existing facilities to support new services, according to a recent Modern Healthcare survey. While demand for inpatient beds remains strong, many health care organizations are focused on growing their outpatient and “medtail” footprints to better position... READ MORE
Tags: Health Care Real Estate, Health Care Real Estate Briefing
[06/20/24]
Posted on June 20, 2024 in Health Law News
Published by: Hall Render
Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework. Hall Render’s PE team of attorneys and advisors leverage... READ MORE
Tags: PRIVATE EQUITY, Private Equity Deal Spotlight
[06/20/24]
Posted on June 20, 2024 in Health Law News
Published by: Hall Render
What Is a Memorandum of Lease? A memorandum of lease or notice of lease is a short, recordable instrument used to place third parties on notice that there is a leasehold interest affecting real estate. A memorandum of lease outlines certain terms of an underlying lease agreement, including the names and addresses of the... READ MORE
Tags: Leaseholder Rights, Memorandum of Lease, Real Estate
[06/18/24]
Posted on June 18, 2024 in Health Law News
Published by: Hall Render
On June 13, 2024, the Supreme Court of the United States unanimously rejected a challenge to the U.S. Food & Drug Administration (“FDA”) approval and regulation of mifepristone (brand name “Mifeprix”), a drug used in medically induced abortions. In a 9-0 decision delivered by Justice Brett Kavanaugh, the Supreme Court held that the plaintiffs,... READ MORE
Tags: FDA, Mifepristone, Mifeprix, U.S. Food & Drug Administration
[06/14/24]
Posted on June 14, 2024 in Health Law News
Published by: Hall Render
The Federal Reserve announced that its key interest rate will remain unchanged but signaled it will consider cutting rates later this year. Inflation is sitting at around 2.8% and the Federal Reserve would like to see inflation at 2%. If inflation continues to cool off, the Federal Reserve expects four rate cuts in 2025... READ MORE
Tags: Health Care Real Estate, Health Care Real Estate Briefing
[06/14/24]
Posted on June 14, 2024 in Health Law News
Published by: Hall Render
On June 10, 2024, the Supreme Court of the United States (“Supreme Court”) agreed to consider an appeal on behalf of more than 200 hospitals* in Advocate Christ Medical Center, et al v. Becerra, challenging the manner in which the Centers for Medicare and Medicaid Services (“CMS”) calculates a hospital’s Disproportionate Share Hospital (“DSH”) payments.... READ MORE
Tags: cms, Disproportionate Share Hospital payments, DSH payments, Provider Reimbursement Review Board, Supplemental Security Income